Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7610-7618
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Group | IgA (g/L) | t | P value | IgM (g/L) | t | P value | ||
Pre-treatment Post-treatment | Post-treatment Post-treatment | Pre-treatment Post-treatment | Post-treatment Post-treatment | |||||
Observation group (n = 65) | 1.26 ± 0.34 | 1.84 ± 0.65 | -7.23 | 0.012 | 9.08 ± 1.56 | 11.8 ± 1.06 | -6.98 | 0.021 |
Control group (n = 65) | 1.27 ± 0.32 | 1.48 ± 0.63 | -9.67 | 0.007 | 9.03 ± 1.25 | 10.9 ± 1.48 | -9.56 | 0.032 |
t | 0.765 | 6.165 | 0.655 | 2.418 | ||||
P value | 0.724 | 0.014 | 0.751 | 0.012 |
- Citation: Cao JY, Wang YC, Deng XX. Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma. World J Clin Cases 2023; 11(31): 7610-7618
- URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7610.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7610